RENO, Nev.--(BUSINESS WIRE)--Lifeline Biotechnologies, Inc. (Pink Sheets:LBTN) today announced that it has finalized and executed the Agreement for the, what is anticipated to be, final stage development of its interpretive system, a system designed to assist in the early detection of breast cancer.
